Parallel Advisors’s iRadimed IRMD Stock Holding History

Parallel Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.98K	Sell	73 -107	-59%	-$9.74K	﹤0.01%	3079
2026 Q1	$17.3K	Buy	180 +107	+147%	+$10.7K	﹤0.01%	2534
2025 Q4	$7.1K	Buy	73 +7	+11%	+$601	﹤0.01%	2739
2025 Q3	$4.7K	Buy	66 +41	+164%	+$2.73K	﹤0.01%	2803
2025 Q2	$1.5K	Buy	25 +16	+178%	+$877	﹤0.01%	3114
2025 Q1	$472	Hold	9	–	–	﹤0.01%	3244
2024 Q4	$495	Hold	9	–	–	﹤0.01%	3225
2024 Q3	$453	Buy	9 +6	+200%	+$277	﹤0.01%	3196
2024 Q2	$132	Buy	+3	New	+$128	﹤0.01%	3236
2022 Q2	–	Sell	-2	Closed	–	–	3163
2022 Q1	$0	Sell	2 -55	-96%	-$2.54K	﹤0.01%	3112
2021 Q4	$3K	Buy	+57	New	+$2.3K	﹤0.01%	2584

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parallel Advisors's IRMD Position: Q2 2026 in Review

Parallel Advisors reduced its iRadimed (IRMD) stake by 59% in Q2 2026, selling an estimated $9.74K and leaving 73 shares worth $6.98K. The position accounts for ﹤0.01% of the portfolio, ranked #3079.

Parallel Advisors first reported a position in IRMD in Q4 2021 and has held it in 11 quarters since. The position peaked at $17.3K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Parallel Advisors held 73 shares of iRadimed worth $6.98K as of Q2 2026.
Parallel Advisors sold 107 iRadimed shares in Q2 2026, an estimated $9.74K.
iRadimed made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3079 holding.
Parallel Advisors first reported a position in iRadimed in Q4 2021 and has held it in 11 quarters since.
Parallel Advisors's iRadimed position peaked at $17.3K in Q1 2026.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.